GSK institutional holders

Mar 31, 2026 filings. Quarterly 13F reports arrive up to 45 days after quarter end; this register is filed through May 29, 2026.

1,018 institutional managers reported holding GSK for the quarter ended Mar 31, 2026. Together they hold about 19% of shares outstanding; the top 10 hold 13%. 134 opened new positions; 106 closed out. Complete ranked register from SEC 13F filings.

Largest holders

managershares% outvalue (Mar 31, 2026 close)changeheld since
FMR (Fidelity)67.66M3.34%$3.73Bunchanged≤2013
Dodge & Cox58.66M2.90%$3.24Btrimmed -14.4%≤2013
Fisher Investments34.52M1.70%$1.90Badded +4%≤2013
PRIMECAP Management25.20M1.24%$1.39Bunchanged≤2013
Pacer Advisors, INC.16.03M0.79%$884.5Madded +274.5%2017 Q2
Acadian Asset Management11.80M0.58%$650.9Madded +31.6%2021 Q1
Wellington Management11.72M0.58%$646.5Mtrimmed -6.7%2022 Q3
Morgan Stanley11.03M0.55%$608.6Madded +89.2%≤2013
Goldman Sachs9.59M0.47%$529.1Madded +32.5%≤2013
JTC Employer Solutions Trustee LTD9.04M0.45%$498.9Mtrimmed -37.3%2021 Q2
Royal Bank OF Canada7.51M0.37%$414.2Mtrimmed -11.5%≤2013
T. Rowe Price7.32M0.36%$404.0Mtrimmed -7.2%≤2013
State Street6.00M0.30%$331.0Mtrimmed -4.1%≤2013
Holocene Advisors5.52M0.27%$304.5Mtrimmed -32%2023 Q1
Mondrian Investment Partners LTD4.99M0.25%$275.2Mtrimmed -14.1%≤2013
Bank OF Montreal /CAN/4.64M0.23%$256.0Madded +78.5%≤2013
BlackRock3.55M0.17%$195.9Madded +95.7%≤2013
Grantham, Mayo, Van Otterloo & CO. LLC3.52M0.17%$194.4Madded +1%2016 Q1
Hotchkis & Wiley Capital Management LLC3.48M0.17%$192.1Mtrimmed -4.8%2014 Q1
Equity Investment CORP3.22M0.16%$177.7Mtrimmed -21.6%2016 Q4
Connor, Clark & Lunn Investment Management LTD.2.82M0.14%$155.5Madded +62.2%2024 Q2
Dimensional Fund Advisors2.59M0.13%$142.7Madded +3.5%≤2013
Manufacturers Life Insurance Company, THE2.38M0.12%$131.2Mtrimmed -35.2%2021 Q2
SEI Investments CO2.29M0.11%$126.2Madded +40.1%2013 Q4
Bank OF America CORP /DE/2.21M0.11%$121.7Mtrimmed -41.2%≤2013
BNP Paribas Financial Markets2.16M0.11%$119.0Madded +240.4%2024 Q4
UBS2.12M0.10%$117.2Mtrimmed -66.2%≤2013
Envestnet Asset Management INC1.84M0.09%$101.4Mtrimmed -30.5%≤2013
Eversept Partners, LP1.79M0.09%$98.5Mtrimmed -33.4%2018 Q1
Northern Trust1.75M0.09%$96.5Madded +2.8%≤2013
Letko, Brosseau & Associates INC1.64M0.08%$90.7Mtrimmed -1.8%≤2013
Miller Howard Investments INC /NY1.63M0.08%$89.9Mtrimmed -0.8%2024 Q4
Arrowstreet Capital1.62M0.08%$89.5Mtrimmed -28.4%2025 Q4
American Century Companies INC1.62M0.08%$89.2Madded +31.2%2019 Q4
Aristotle Capital Management, LLC1.53M0.07%$84.3Mtrimmed -2.1%2021 Q1
Citigroup INC1.50M0.07%$82.5Madded +675.1%≤2013
Brandes Investment Partners, LP1.45M0.07%$80.2Mtrimmed -15.7%≤2013
Wells Fargo & COMPANY/MN1.41M0.07%$77.5Mtrimmed -44.6%≤2013
Raymond James Financial INC1.37M0.07%$75.7Mtrimmed -44.6%≤2013
Callodine Capital Management, LP1.26M0.06%$69.5Madded +25.4%2022 Q4
Mariner, LLC1.23M0.06%$67.9Munchanged2018 Q1
Alyeska Investment Group1.21M0.06%$66.8Madded +254.4%2025 Q1
VAN ECK Associates CORP1.07M0.05%$58.9Mtrimmed -10.7%≤2013
Russell Investments Group, LTD.1.05M0.05%$58.0Madded +13.2%2020 Q4
Douglas Lane & Associates, LLC1.01M0.05%$55.7Mtrimmed -3.4%2019 Q3
LMR Partners LLP980.5k0.05%$54.1Mopened2024 Q1
Franklin Resources942.4k0.05%$52.0Madded +342.9%≤2013
LPL Financial LLC884.0k0.04%$48.8Mtrimmed -44.1%≤2013
BNY Mellon808.1k0.04%$44.6Mtrimmed -13.8%≤2013
NEW York State Common Retirement Fund728.5k0.04%$40.2Madded +47.3%2021 Q3

Largest 50 of 1,018 shown; the full ranked, searchable register is at boothcheck.com/holders/GSK. Related filers are grouped using the filings' own included-manager declarations. Historically, several managers opening new positions in the same quarter said almost nothing about the quarter that followed (59,118 cases since 2013). A filed record, not a forecast. Nothing here is investment advice.

GSK research report · GSK stock page